Improving the data, methods and analysis used to inform drug policy

In programme
16 sessions 65 presentations View the programme

About

The thematic track co-produced by the International Society for the Study of Drug Policy (ISSDP) emphasizes high-quality research that develops robust data, improved monitoring approaches, and multidisciplinary analytic methods that can provide a strong scientific basis for the development of new drug policies, and improve the implementation and evaluation of their impact.

Sessions

  • Plenary session
  • Poster session
  • Big debate
  • Structured session
  • Workshop
  • Oral presentation session
  • Short communication session
  • Poster guided tour

Wednesday, 23 October

10:50

Innovative methods for exploring new drug-related trends

10:50 to 12:20
Insights zone 4 (I4)
João Matias
12:20

Measuring drug use to monitor trends in different populations - ISSDP poster session 1

12:20 to 13:20
Guided poster tours room
Nicola Singleton
13:20

Modelling the impact of decriminalisation

13:20 to 14:50
Networking zone 1 (N1)
Rosalie Pacula
15:00

Needs-based planning for substance use treatment systems: The new generation of principles, methods and models

15:00 to 16:30
Insights zone 4 (I4)
Thomas Babor
16:50

Developing tools for monitoring of drug policy and practice from the view point of civil society organisations in Europe

16:50 to 18:20
Insights zone 1 (I1)
Eberhard Schatz
18:30

Innovative approaches for assessing or impacting demand for substances

18:30 to 19:30
Central square 1 (C1)
Anne Line Bretteville-Jensen

Thursday, 24 October

12:20

Making better use of existing data through standardisation, methods and analysis - ISSDP poster session 2

12:20 to 13:20
Guided poster tours room
Rosalie Pacula
13:20
Lessons from the past applied to the future

Post-marketing prescription drug mosaic surveillance

13:20 to 14:50
Main stage
Richard Dart

Using new technology and innovative methods to measure substance use and related harm

13:20 to 14:50
Networking zone 1 (N1)
Peter Reuter
15:00
Methodological challenges and comparative analyses in five European countries

Insight into the dynamics of substance use (research) in nightlife settings

15:00 to 16:30
Networking zone 1 (N1)
João Matias
16:50

Methods and measurement of economic cost of substance use

16:50 to 18:20
Central square 3 (C3)
Rosalie Pacula
18:30
Lessons from the field

Measuring and monitoring drug policy for research, surveillance and practice

18:30 to 19:30
Networking zone 1 (N1)
Rosalie Pacula

Cannabis labelling and health warnings: use and impacts

18:30 to 19:30
Insights zone 4 (I4)
Hanan Abramovici

Prevention science and measurement of demand reduction quality standards

18:30 to 19:30
Central square 1 (C1)
Nicola Singleton

Friday, 25 October

09:00

Studying the operation of new forms of cannabis supply

09:00 to 10:30
Central square 1 (C1)
Caitlin Hughes
10:45

Approaches to support the development of an evaluative culture to promote better drug policy for the future

10:45 to 12:15
Networking zone 2 (N2)
Liesbeth Vandam

Presentations

  • Plenary session
  • Poster session
  • Big debate
  • Structured session
  • Workshop
  • Oral presentation session
  • Short communication session
  • Poster guided tour

Wednesday, 23 October

11:00
Oral presentation

Lessons learned from 25 years of drug checking in the Netherlands

11:00 to 11:15
Insights zone 4 (I4)
Laura Smit-Rigter
11:15
Oral presentation

Harm reduction agencies and monitoring the responses to drug-related harm

11:15 to 11:30
Insights zone 4 (I4)
Tuukka Tammi
11:30
Oral presentation

Monitoring drug use through wastewater analysis in Spain

11:30 to 11:45
Insights zone 4 (I4)
José Benito Quintana
11:45
Oral presentation

ESCAPE (European Syringe Collection & Analysis Project Enterprise): a multi-city study of monitoring consumption trends of people who inject drugs

11:45 to 12:00
Insights zone 4 (I4)
Thomas Néfau
12:20
Poster

Illegal drug trends in Taiwan, 2009-2018

12:20 to 13:20
Guided poster tours room
Kai-Hsiang Kang
Poster

Gender convergence in alcohol consumption: outcomes from general population survey on drugs, Portugal 2001-2016/17

12:20 to 13:20
Guided poster tours room
Clara Vital
Poster

Monitoring recreational drug use in Switzerland

12:20 to 13:20
Guided poster tours room
Dominique Schori
Poster

Prevalence and patterns of drug use indicator (‘GPS’)

12:20 to 13:20
Guided poster tours room
Federica Mathis
Poster

European web survey on drugs: patterns of use

12:20 to 13:20
Guided poster tours room
João Matias
13:30
Oral presentation

Models for the decriminalisation, depenalisation and diversion of illicit drug possession: an international realist review

13:30 to 13:45
Networking zone 1 (N1)
Caitlin Hughes
13:45
Oral presentation

To what extent will the drug-crime nexus remain after drug laws liberalisation? An examination of criminal charges among patients in treatment for cannabis use disorders and controls under varied drug policy regimes

13:45 to 14:00
Networking zone 1 (N1)
Anne Line Bretteville-Jensen
14:00
Oral presentation

The law enforcement costs of de facto 'criminalising' drug possession: the Italian experience

14:00 to 14:15
Networking zone 1 (N1)
Davide Fortin
14:15
Oral presentation

Introducing a new cannabis decriminalisation policy: The unintentional effects on cannabis perceptions and use among Israeli youth

14:15 to 14:30
Networking zone 1 (N1)
Yossi Harel-Fisch
15:10
Oral presentation

Measuring unmet demand for alcohol and other treatment: the application of an Australian population-based planning model

15:10 to 15:25
Insights zone 4 (I4)
Alison Ritter
15:25
Oral presentation

The treatment demand indicator in Europe: A common monitoring tool across 30 countries and its value for treatment systems planning

15:25 to 15:40
Insights zone 4 (I4)
Linda Montanari
15:40
Oral presentation

Development of a needs-based planning model to estimate required capacity of a substance use treatment system: A Canadian model

15:40 to 15:55
Insights zone 4 (I4)
Brian Rush
15:55
Oral presentation

Users of alcohol and other drugs residing in the Metropolitan Region of São Paulo: Basis for the planning of a treatment system

15:55 to 16:10
Insights zone 4 (I4)
Daniela Mota
16:10
Oral presentation

The evolution of methods to estimate specialist alcohol treatment capacity and access in the United Kingdom

16:10 to 16:25
Insights zone 4 (I4)
Colin Drummond
16:50

Description of the contents of the workshop

16:50 to 17:00
Insights zone 1 (I1)
Eberhard Schatz
17:00
Oral presentation

Introduction and short presentation on harm reduction monitoring

17:00 to 17:15
Insights zone 1 (I1)
Dagmar Hedrich
17:15
Oral presentation

Introduction of methods developed for CSO monitoring

17:15 to 17:30
Insights zone 1 (I1)
Tuukka Tammi
17:30
Oral presentation

Focus on monitoring HCV, overdose prevention and new drug trends

17:30 to 17:45
Insights zone 1 (I1)
Daan van der Gouwe
18:30
Oral presentation

USODROGAS.PT: Portugal's drug use: a web based survey

18:30 to 18:45
Central square 1 (C1)
André Tadeu
18:45
Oral presentation

Partnering with persons in long-term recovery from substance use disorder: experiences from a collaborative research project

18:45 to 19:00
Central square 1 (C1)
Henning Pettersen
19:00
Oral presentation

Validation of the Routine Opioid Outcome Monitoring (ROOM) screening tool in patients prescribed opioids for chronic pain

19:00 to 19:15
Central square 1 (C1)
Suzanne Nielsen
19:15
Oral presentation

Adoption of publication procedures to improve research integrity by alcohol and other drug journals

19:15 to 19:30
Central square 1 (C1)
Dennis Gorman

Thursday, 24 October

12:20
Poster

Epidemiology of illicit drug use and policy evaluation: the heroin epidemics example

12:20 to 13:20
Guided poster tours room
Carla Rossi
Poster

Scalable family therapy training materials for adolescents with substance use disorder (UNFT)

12:20 to 13:20
Guided poster tours room
Anja Busse
Poster

Community Reinforcement and Family Training (CRAFT) - a cluster randomised controlled trial comparing individual, group and self-help interventions.

12:20 to 13:20
Guided poster tours room
Randi Bilberg
Poster

Can environmental prevention effectively complement efforts in responding to the psychoactive substance abuse among forensic patients?

12:20 to 13:20
Guided poster tours room
Poster

Development of the UNODC-WHO quality assurance mechanism and standards for the treatment of drug use disorders

12:20 to 13:20
Guided poster tours room
Annette Dale-PereraAnja Busse
Poster

Preliminary methodological analysis on the lexicometric assessment of laws and drugs policies and evaluation of social outcomes

12:20 to 13:20
Guided poster tours room
Carla Rossi
Poster

Development of the UNODC-WHO quality assurance mechanism and standards for the treatment of drug use disorders

12:20 to 13:20
Guided poster tours room
Wataru Kashino
13:30
Oral presentation

'A more accurate understanding of drug use': a critical analysis of wastewater analysis technology for drug policy

13:30 to 13:45
Networking zone 1 (N1)
Kari Lancaster
Oral presentation

Principles and strategies for post-marketing surveillance of prescription drugs

13:30 to 13:45
Main stage
Richard Dart
13:45
Oral presentation

Beyond the substances: a multi-criteria analysis of spread of drugs in Europe

13:45 to 14:00
Networking zone 1 (N1)
Giuliano Resce
Oral presentation

Better methods: Novel methods and analyses to better understand prescription drug misuse

13:45 to 14:00
Main stage
Janetta Iwanicki
14:00
Oral presentation

A smartphone app to assess alcohol consumption behaviours: development, validity, compliance and reactivity

14:00 to 14:15
Networking zone 1 (N1)
Rob Hester
Oral presentation

Prescription opioid misuse in Europe: Past, present, and future

14:00 to 14:15
Main stage
Marta Torrens Melich
14:15
Oral presentation

New and fully automated workflow for alcohol consumption and drugs of abuse monitoring from one single blood droplet

14:15 to 14:30
Networking zone 1 (N1)
Marc Luginbühl
Oral presentation

The future of prescription drug abuse beyond opioids: A U.K. perspective

14:15 to 14:30
Main stage
David Wood
15:10
Oral presentation

‘EMSS Nightlife survey’: design and snapshot of findings in 5 European countries

15:10 to 15:25
Networking zone 1 (N1)
Meryem Grabski
15:25
Oral presentation

Methodological challenges: comparing different samples and sampling strategies

15:25 to 15:40
Networking zone 1 (N1)
Jon Waldron
15:40
Oral presentation

Ecological momentary assessment of substance use (consequences) among ecstasy users

15:40 to 15:55
Networking zone 1 (N1)
Ruben van Beek
15:55
Oral presentation

Contextual analysis and comparison of nightlife cultures in five European countries

15:55 to 16:10
Networking zone 1 (N1)
Tina Van Havere
16:10
Oral presentation

Insight into the reliability of self-report of substance use in nightlife populations: a breath sampling study

16:10 to 16:25
Networking zone 1 (N1)
Kristin Feltmann
16:50
Oral presentation

Modeling economical costs of alcohol consumption in Germany: the GECO-ALC1 project

16:50 to 17:05
Central square 3 (C3)
Jakob Manthey
17:05
Oral presentation

Estimating substance use costs and harms in Canada

17:05 to 17:20
Central square 3 (C3)
Matthew Young
17:20
Oral presentation

Morbi-mortality consequences of misuse of psychoactive prescription drugs in Portugal: a retrospective observational study - the MisuMedPT project

17:20 to 17:35
Central square 3 (C3)
Ana Araújo
18:30
Oral presentation

Babel and Bleak House; what ELDD can and can’t tell us about drug laws in 30 countries

18:30 to 19:30
Networking zone 1 (N1)
Brendan Hughes
Oral presentation

tba

18:30 to 19:30
Networking zone 1 (N1)
Scott Burris
18:40
Oral presentation

Use of an adapted version of the community readiness assessment to examine the current state of alcohol prevention in communities in Spain and Portugal

18:40 to 18:55
Central square 1 (C1)
Claudia Pischke
Oral presentation

Cannabis labelling and consumer understanding of THC levels and serving sizes.

18:40 to 18:55
Insights zone 4 (I4)
Samantha Goodman
18:55
Oral presentation

Building systems to promote prevention science: challenges and strategies

18:55 to 19:10
Central square 1 (C1)
Peer van der Kreeft
Oral presentation

The impact of cannabis health warning labels on risk awareness and behaviour

18:55 to 19:10
Insights zone 4 (I4)
Adam Winstock
19:10
Oral presentation

Minimum quality standards in drug demand reduction - from policy consensus to assessment and implementation

19:10 to 19:25
Central square 1 (C1)
Matej Košir
Oral presentation

The efficacy of health warnings and package branding on perceptions of cannabis products among youth and young adults.

19:10 to 19:25
Insights zone 4 (I4)
Cesar Leos-Toro

Friday, 25 October

09:10
Oral presentation

Presence and practices of cannabis social clubs within the European Union

09:10 to 09:25
Central square 1 (C1)
Mafalda Pardal
09:25
Oral presentation

Initial lessons and next steps for a public health approach to cannabis regulation in Canada

09:25 to 09:40
Central square 1 (C1)
Rebecca Jesseman
09:40
Oral presentation

Implementing cannabis regulation to achieve public health and safety goals in California – assessing the successes and challenges of the first year of regulation

09:40 to 09:55
Central square 1 (C1)
Jennifer Price
09:55
Oral presentation

Development of new measures of cannabis market exposure: a case study in Colorado

09:55 to 10:10
Central square 1 (C1)
Rosalie Pacula
10:55
Oral presentation

Evaluations of recreational cannabis legalisation in the US – overview and key lessons for policymakers

10:55 to 11:10
Networking zone 2 (N2)
Beau Kilmer
11:10
Oral presentation

Legalising cannabis for recreational purposes in Canada – practical challenges and opportunities for evaluating implementation and outcomes

11:10 to 11:25
Networking zone 2 (N2)
Rebecca Jesseman
11:25
Oral presentation

The role of evaluation in the development of the EU approach on drugs

11:25 to 11:40
Networking zone 2 (N2)
Danilo Ballotta
11:40
Oral presentation

Developing a flexible support package for EU Member States: EMCDDA’s ‘realistic’ policy evaluation approach

11:40 to 11:55
Networking zone 2 (N2)
Nicola Singleton
View all tracks